BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3306001)

  • 1. Quest to improve marrow transplant success yields new approaches to graft-vs-host disease.
    Kirn TF
    JAMA; 1987 Sep; 258(11):1438-9. PubMed ID: 3306001
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of thalidomide to control bronchiolitis obliterans post bone marrow transplant.
    Heaton DC
    Bone Marrow Transplant; 1989 Sep; 4(5):598. PubMed ID: 2790340
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children.
    Rovelli A; Arrigo C; Nesi F; Balduzzi A; Nicolini B; Locasciulli A; Vassallo E; Miniero R; Uderzo C
    Bone Marrow Transplant; 1998 Mar; 21(6):577-81. PubMed ID: 9543061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment with thalidomide of acute graft-versus-host disease after bone-marrow transplantation.
    Lim SH; McWhannell A; Vora AJ; Boughton BJ
    Lancet; 1988 Jan; 1(8577):117. PubMed ID: 2891954
    [No Abstract]   [Full Text] [Related]  

  • 5. Thalidomide induction of bone marrow transplantation tolerance.
    Vogelsang GB; Hess AD; Gordon G; Brundrette R; Santos GW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2658-61. PubMed ID: 3547944
    [No Abstract]   [Full Text] [Related]  

  • 6. Thalidomide as therapy for intestinal chronic GVHD.
    Lopez J; Ulibarrena C; Garcia-Laraña J; Odriozola J; Pérez de Oteyza J; Sastre JL; Navarro JL
    Bone Marrow Transplant; 1993 Mar; 11(3):251-2. PubMed ID: 8467293
    [No Abstract]   [Full Text] [Related]  

  • 7. Thalidomide for graft-versus-host disease after bone marrow transplantation.
    Saurat JH; Camenzind M; Helg C; Chapuis B
    Lancet; 1988 Feb; 1(8581):359. PubMed ID: 2893167
    [No Abstract]   [Full Text] [Related]  

  • 8. Thalidomide in the management of chronic graft-versus-host disease in children following bone marrow transplantation.
    Cole CH; Rogers PC; Pritchard S; Phillips G; Chan KW
    Bone Marrow Transplant; 1994 Dec; 14(6):937-42. PubMed ID: 7711671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of thalidomide for CGVHD defended.
    Altomonte V
    Oncol Nurs Forum; 1993 Apr; 20(3):428. PubMed ID: 8497414
    [No Abstract]   [Full Text] [Related]  

  • 10. Thalidomide for treatment of graft-versus-host disease.
    Vogelsang GB; Hess AD; Santos GW
    Bone Marrow Transplant; 1988 Sep; 3(5):393-8. PubMed ID: 3056547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches to graft-versus-host disease following bone marrow transplantation in monkeys and man.
    Dicke KA; Spitzer G; Peters L; Stevens EE; Hendriks W; McCredie tkb
    Transplant Proc; 1978 Mar; 10(1):217-21. PubMed ID: 416529
    [No Abstract]   [Full Text] [Related]  

  • 12. Thalidomide for graft-versus-host disease.
    McCarthy DM; Kanfer E; Taylor J; Barrett AJ
    Lancet; 1988 Nov; 2(8620):1135. PubMed ID: 2903342
    [No Abstract]   [Full Text] [Related]  

  • 13. Phases in a drug's use.
    Duffin J
    CMAJ; 1992 Sep; 147(5):588. PubMed ID: 1521204
    [No Abstract]   [Full Text] [Related]  

  • 14. T cell depletion in bone marrow transplantation for leukemia: current results and future directions.
    Butturini A; Gale RP
    Bone Marrow Transplant; 1988 May; 3(3):185-92. PubMed ID: 3048485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide for severe acute graft-versus-host disease.
    Ringdén O; Aschan J; Westerberg L
    Lancet; 1988 Sep; 2(8610):568. PubMed ID: 2900947
    [No Abstract]   [Full Text] [Related]  

  • 16. Perspectives in marrow graft T-cell depletion in allogeneic matched related bone marrow transplantation.
    Tiberghien P; Hervé P
    Transfus Sci; 1992; 13(4):443-54. PubMed ID: 10147740
    [No Abstract]   [Full Text] [Related]  

  • 17. Graft-versus-host disease after marrow transplantation.
    Lancet; 1984 Mar; 1(8375):491-2. PubMed ID: 6142212
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of the microbial flora on incidence of graft-versus-host disease in human allogeneic bone marrow transplantation.
    Schmeiser T; Kurrle E; Arnold R; Heit W; Krieger D; Kubanek B; Heimpel H
    Prog Clin Biol Res; 1985; 181():433-5. PubMed ID: 3895247
    [No Abstract]   [Full Text] [Related]  

  • 19. Thalidomide back in good graces--seems to help GVHD patients.
    Oncology (Williston Park); 1988 Sep; 2(9):29. PubMed ID: 3275064
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thalidomide 1989].
    Codina C
    Med Clin (Barc); 1989 Apr; 92(15):571-2. PubMed ID: 2666770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.